{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:32:04Z","timestamp":1793050324273,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","award":["Department of Pediatrics in association with Cardinal Glennon Foundation"],"award-info":[{"award-number":["Department of Pediatrics in association with Cardinal Glennon Foundation"]}],"id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","award":["Graduate Scholarship"],"award-info":[{"award-number":["Graduate Scholarship"]}],"id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13346-020-00714-7","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:10:32Z","timestamp":1580249432000},"page":"1341-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biodegradable polyethylene glycol hydrogels for sustained release and enhanced stability of rhGALNS enzyme"],"prefix":"10.1007","volume":"10","author":[{"given":"Era","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saahil","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiragi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birju","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-5789","authenticated-orcid":false,"given":"Adriana M.","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7648-8351","authenticated-orcid":false,"given":"Silviya P.","family":"Zustiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"714_CR1","unstructured":"Neufeld E, Muenzer J. The mucopolysaccharidoses. In: The metabolic and molecular bases of inherited diseases. 8th. ed. New York: McGraw Hill; 2001."},{"key":"714_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Tomatsu S, Gottesman GS, Smith M, Orii T, International Morquio A. Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis. 2007;30:165\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"714_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","volume":"12","author":"S Tomatsu","year":"2011","unstructured":"Tomatsu S, Monta\u00f1o A, Oikawa H, Smith M, Barrera L, Chinen Y, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol. 2011;12:931\u201345.","journal-title":"Curr Pharm Biotechnol"},{"key":"714_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","volume":"109","author":"E Yasuda","year":"2013","unstructured":"Yasuda E, Fushimi K, Suzuki Y, Shimizu K, Takami T, Zustin J, et al. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol Genet Metab. 2013;109:301\u201311.","journal-title":"Mol Genet Metab"},{"key":"714_CR5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/21678707.2017.1366900","volume":"5","author":"Y Puckett","year":"2017","unstructured":"Puckett Y, Mulister H, Monta\u00f1o AM. Enzyme replacement therapy for mucopolysaccharidosis IVA (Morquio A syndrome): milestones and challenges. Expert Opin Orphan Drugs. 2017;5:741\u201352.","journal-title":"Expert Opin Orphan Drugs"},{"key":"714_CR6","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1055\/s-0038-1667346","volume":"8","author":"A Vartanyan","year":"2018","unstructured":"Vartanyan A, Monta\u00f1o AM. Causal therapies in mucopolysaccharidoses: enzyme replacement therapy. J Child Sci. 2018;8:e156\u2013e62.","journal-title":"J Child Sci"},{"key":"714_CR7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/oxfordjournals.jbchem.a123697","volume":"110","author":"M Masue","year":"1991","unstructured":"Masue M, Sukegawa K, Orii T, Hashimoto T. N-acetylgalactosamine-6-sulfate sulfatase in human placenta: purification and characteristics. J Biochem. 1991;110:965\u201370.","journal-title":"J Biochem"},{"key":"714_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","volume":"91","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu S, Monta\u00f1o AM, Gutierrez M, Grubb JH, Oikawa H, Dung VC, et al. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. Mol Genet Metab. 2007;91:69\u201378.","journal-title":"Mol Genet Metab"},{"key":"714_CR9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jmb.2012.08.020","volume":"423","author":"Y Rivera-Col\u00f3n","year":"2012","unstructured":"Rivera-Col\u00f3n Y, Schutsky EK, Kita AZ, Garman SC. The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A. J Mol Biol. 2012;423:736\u201351.","journal-title":"J Mol Biol"},{"key":"714_CR10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF01923507","volume":"48","author":"A Hasilik","year":"1992","unstructured":"Hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia. 1992;48:130\u201351.","journal-title":"Experientia"},{"key":"714_CR11","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","volume":"264","author":"NM Dahms","year":"1989","unstructured":"Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem. 1989;264:12115\u20138.","journal-title":"J Biol Chem"},{"key":"714_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-5793(98)00065-9","volume":"423","author":"T Dierks","year":"1998","unstructured":"Dierks T, Lecca MR, Schmidt B, von Figura K. Conversion of cysteine to formylglycine in eukaryotic sulfatases occurs by a common mechanism in the endoplasmic reticulum. FEBS Lett. 1998;423:61\u20135.","journal-title":"FEBS Lett"},{"key":"714_CR13","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","volume":"101","author":"JH LeBowitz","year":"2004","unstructured":"LeBowitz JH, Grubb JH, Maga JA, Schmiel DH, Vogler C, Sly WS. Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice. Proc Natl Acad Sci U S A. 2004;101:3083\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"714_CR14","doi-asserted-by":"crossref","unstructured":"Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA, et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis. 2014; 37(6):979\u201390","DOI":"10.1007\/s10545-014-9715-6"},{"key":"714_CR15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford M, Lo JH. Elosulfase alfa: first global approval. Drugs. 2014;74:713\u20138.","journal-title":"Drugs"},{"key":"714_CR16","first-page":"iii","volume":"10","author":"M Connock","year":"2006","unstructured":"Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, et al. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry\u2019s disease and mucopolysaccharidosis type 1. Health Technol Assess. 2006;10:iii\u2013v ix-113.","journal-title":"Health Technol Assess"},{"key":"714_CR17","first-page":"2686","volume":"118","author":"K Ponder","year":"2008","unstructured":"Ponder K. Immune response hinders therapy for lysosomal storage diseases. J Clin Invest. 2008;118:2686\u20139.","journal-title":"J Clin Invest"},{"key":"714_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/bit.22911","volume":"108","author":"SP Zustiak","year":"2011","unstructured":"Zustiak SP, Leach JB. Characterization of protein release from hydrolytically degradable poly (ethylene glycol) hydrogels. Biotechnol Bioeng. 2011;108:197\u2013206.","journal-title":"Biotechnol Bioeng"},{"key":"714_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11095-008-9801-2","volume":"26","author":"C-C Lin","year":"2009","unstructured":"Lin C-C, Anseth KS. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res. 2009;26:631\u201343.","journal-title":"Pharm Res"},{"key":"714_CR20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","volume":"60","author":"M Hamidi","year":"2008","unstructured":"Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev. 2008;60:1638\u201349.","journal-title":"Adv Drug Deliv Rev"},{"key":"714_CR21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.msec.2017.05.096","volume":"79","author":"K Varaprasad","year":"2017","unstructured":"Varaprasad K, Raghavendra GM, Jayaramudu T, Yallapu MM, Sadiku R. A mini review on hydrogels classification and recent developments in miscellaneous applications. Mater Sci Eng C Mater Biol Appl. 2017;79:958\u201371.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"714_CR22","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.biomaterials.2005.08.013","volume":"27","author":"AJ DeFail","year":"2006","unstructured":"DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-\u03b2 1 from microspheres embedded within biodegradable hydrogels. Biomaterials. 2006;27:1579\u201385.","journal-title":"Biomaterials"},{"key":"714_CR23","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1002\/jbm.a.36187","volume":"105","author":"E Jain","year":"2017","unstructured":"Jain E, Sheth S, Dunn A, Zustiak SP, Sell SA. Sustained release of multicomponent platelet-rich plasma proteins from hydrolytically degradable PEG hydrogels. J Biomed Mater Res A. 2017;105:3304\u201314.","journal-title":"J Biomed Mater Res A"},{"key":"714_CR24","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/j.biomaterials.2003.11.028","volume":"25","author":"C Ribeiro","year":"2004","unstructured":"Ribeiro C, Barrias C, Barbosa M. Calcium phosphate-alginate microspheres as enzyme delivery matrices. Biomaterials. 2004;25:4363\u201373.","journal-title":"Biomaterials"},{"key":"714_CR25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/02652049809008253","volume":"15","author":"G Crotts","year":"1998","unstructured":"Crotts G, Park TG. Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul. 1998;15:699\u2013713.","journal-title":"J Microencapsul"},{"key":"714_CR26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2:214\u201321.","journal-title":"Nat Rev Drug Discov"},{"key":"714_CR27","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1039\/c0sm00111b","volume":"6","author":"SP Zustiak","year":"2010","unstructured":"Zustiak SP, Boukari H, Leach JB. Solute diffusion and interactions in cross-linked poly (ethylene glycol) hydrogels studied by fluorescence correlation spectroscopy. Soft Matter. 2010;6:3609\u201318.","journal-title":"Soft Matter"},{"key":"714_CR28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jconrel.2004.10.029","volume":"102","author":"P Van de Wetering","year":"2005","unstructured":"Van de Wetering P, Metters AT, Schoenmakers RG, Hubbell JA. Poly (ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. J Control Release. 2005;102:619\u201327.","journal-title":"J Control Release"},{"key":"714_CR29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbm.a.35545","volume":"104","author":"Y Liang","year":"2016","unstructured":"Liang Y, Coffin MV, Manceva SD, Chichester JA, Jones RM, Kiick KL. Controlled release of an anthrax toxin-neutralizing antibody from hydrolytically degradable polyethylene glycol hydrogels. J Biomed Mater Res A. 2016;104:113\u201323.","journal-title":"J Biomed Mater Res A"},{"key":"714_CR30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/bm100137q","volume":"11","author":"SP Zustiak","year":"2010","unstructured":"Zustiak SP, Leach JB. Hydrolytically degradable poly (ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules. 2010;11:1348\u201357.","journal-title":"Biomacromolecules"},{"key":"714_CR31","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1039\/C6TB03050E","volume":"5","author":"E Jain","year":"2017","unstructured":"Jain E, Hill L, Canning E, Sell SA, Zustiak SP. Control of gelation, degradation and physical properties of polyethylene glycol hydrogels through the chemical and physical identity of the crosslinker. J Mater Chem B. 2017;5:2679\u201391.","journal-title":"J Mater Chem B"},{"key":"714_CR32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/ma50002a045","volume":"14","author":"M Schmidt","year":"1981","unstructured":"Schmidt M, Burchard W. Translational diffusion and hydrodynamic radius of unperturbed flexible chains. Macromolecules. 1981;14:210\u20131.","journal-title":"Macromolecules"},{"key":"714_CR33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/hmg\/9.9.1283","volume":"9","author":"K Sukegawa","year":"2000","unstructured":"Sukegawa K, Nakamura H, Kato Z, Tomatsu S, Monta\u00f1o AM, Fukao T, et al. Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet. 2000;9:1283\u201390.","journal-title":"Hum Mol Genet"},{"key":"714_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","volume":"187","author":"OP van Diggelen","year":"1990","unstructured":"van Diggelen OP, Zhao H, Kleijer WJ, Janse HC, Poorthuis BJ, van Pelt J, et al. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A). Clin Chim Acta. 1990;187:131\u20139.","journal-title":"Clin Chim Acta"},{"key":"714_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0003-2697(79)90222-7","volume":"100","author":"GL Peterson","year":"1979","unstructured":"Peterson GL. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal Biochem. 1979;100:201\u201320.","journal-title":"Anal Biochem"},{"key":"714_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 1987;5:23\u201336.","journal-title":"J Control Release"},{"key":"714_CR37","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1021\/bm0703564","volume":"8","author":"JL Vanderhooft","year":"2007","unstructured":"Vanderhooft JL, Mann BK, Prestwich GD. Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules. 2007;8:2883\u20139.","journal-title":"Biomacromolecules"},{"key":"714_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bip.1974.360130103","volume":"13","author":"D Magde","year":"1974","unstructured":"Magde D, Elson EL, Webb WW. Fluorescence correlation spectroscopy. II. An experimental realization. Biopolymers. 1974;13:29\u201361.","journal-title":"Biopolymers"},{"key":"714_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/bm025744e","volume":"4","author":"M Lutolf","year":"2003","unstructured":"Lutolf M, Hubbell J. Synthesis and physicochemical characterization of end-linked poly (ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. Biomacromolecules. 2003;4:713\u201322.","journal-title":"Biomacromolecules"},{"key":"714_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1364\/OE.26.000051","volume":"26","author":"SH Huang","year":"2018","unstructured":"Huang SH, Sheth S, Jain E, Jiang X, Zustiak SP, Yang L. Whispering gallery mode resonator sensor for in situ measurements of hydrogel gelation. Opt Express. 2018;26:51\u201362.","journal-title":"Opt Express"},{"key":"714_CR41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00255341","volume":"18","author":"RS Harland","year":"1987","unstructured":"Harland RS, Peppas NA. Solute diffusion in swollen membranes. Polym Bull. 1987;18:553\u20136.","journal-title":"Polym Bull"},{"key":"714_CR42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"E Kakkis","year":"2001","unstructured":"Kakkis E, Muenzer J, Tiller G, Waber L, Belmont J, Passage M, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001;344:182\u20138.","journal-title":"N Engl J Med"},{"key":"714_CR43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","volume":"144","author":"P Harmatz","year":"2004","unstructured":"Harmatz P, Whitley C, Waber L, Pais R, Steiner R, Plecko B, et al. Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr. 2004;144:574\u201380.","journal-title":"J Pediatr"},{"key":"714_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","volume":"91","author":"J Muenzer","year":"2002","unstructured":"Muenzer J, Lamsa J, Garcia A, Dacosta J, Garcia J, Treco D. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): preliminary report. Acta Paediatr Suppl. 2002;91:98\u20139.","journal-title":"Acta Paediatr Suppl"},{"key":"714_CR45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","volume":"8","author":"J Muenzer","year":"2006","unstructured":"Muenzer J, Wraith J, Beck M, Giugliani R, Harmatz P, Eng C, et al. A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med. 2006;8:465\u201373.","journal-title":"Genet Med"},{"key":"714_CR46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu S, Monta\u00f1o AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2007;17:815\u201324.","journal-title":"Hum Mol Genet"},{"key":"714_CR47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","volume":"114","author":"CJ Hendriksz","year":"2015","unstructured":"Hendriksz CJ, Giugliani R, Harmatz P, Mengel E, Guffon N, Valayannopoulos V, et al. Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial. Mol Genet Metab. 2015;114:178\u201385.","journal-title":"Mol Genet Metab"},{"key":"714_CR48","unstructured":"Leuty R. The 5 highest-priced drugs: BioMarin\u2019s $380,000 latest is not even close to top. San Francisco: Business Times; 2014"},{"key":"714_CR49","unstructured":"Williams S. The 5 most expensive drugs in the world in 2015: The Motley Fool; 2015. https:\/\/www.fool.com\/investing\/highgrowth\/2015\/08\/15\/the-5-most-expensive-drugs-in-the-world-in-2015.aspx."},{"key":"714_CR50","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1002\/adma.201402105","volume":"26","author":"A Singh","year":"2014","unstructured":"Singh A, Peppas NA. Hydrogels and scaffolds for immunomodulation. Adv Mater. 2014;26:6530\u201341.","journal-title":"Adv Mater"},{"key":"714_CR51","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1006\/jmbi.2001.5166","volume":"314","author":"DK Eggers","year":"2001","unstructured":"Eggers DK, Valentine JS. Crowding and hydration effects on protein conformation: a study with sol-gel encapsulated proteins. J Mol Biol. 2001;314:911\u201322.","journal-title":"J Mol Biol"},{"key":"714_CR52","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/mt.2010.32","volume":"18","author":"S Tomatsu","year":"2010","unstructured":"Tomatsu S, Monta\u00f1o AM, Dung VC, Ohashi A, Oikawa H, Oguma T, et al. Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome. Mol Ther. 2010;18:1094\u2013102.","journal-title":"Mol Ther"},{"key":"714_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0142-9612(02)00227-2","volume":"24","author":"B Qiu","year":"2003","unstructured":"Qiu B, Stefanos S, Ma J, Lalloo A, Perry BA, Leibowitz MJ, et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly (ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials. 2003;24:11\u20138.","journal-title":"Biomaterials"},{"key":"714_CR54","doi-asserted-by":"crossref","first-page":"e86785","DOI":"10.1371\/journal.pone.0086785","volume":"9","author":"J Kunkel","year":"2014","unstructured":"Kunkel J, Asuri P. Function, structure, and stability of enzymes confined in agarose gels. PLoS One. 2014;9:e86785.","journal-title":"PLoS One"},{"key":"714_CR55","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1039\/C6SM02179D","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Akcora P. Confinement effect on the structure and elasticity of proteins interfacing polymers. Soft Matter. 2017;13:1561\u20138.","journal-title":"Soft Matter"},{"key":"714_CR56","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/pro.5560010907","volume":"1","author":"R Bhat","year":"1992","unstructured":"Bhat R, Timasheff SN. Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols. Protein Sci. 1992;1:1133\u201343.","journal-title":"Protein Sci"},{"key":"714_CR57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","volume":"73","author":"X Huang","year":"2001","unstructured":"Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73:121\u201336.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-020-00714-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00714-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:23:09Z","timestamp":1611706989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-020-00714-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00714-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"28 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"E.J., A.M.M., and S.P.Z. declare competing financial interests: they have US patent application 16\/179,158. The patent covers the underlying concept of the use of hydrogels for lysosomal storage diseases described in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}